{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:36:09Z","timestamp":1790742969384,"version":"4.1.0"},"reference-count":118,"publisher":"Elsevier","isbn-type":[{"value":"9780128154182","type":"print"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1016\/bs.irn.2018.07.028","type":"book-chapter","created":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T16:04:03Z","timestamp":1535126643000},"page":"251-274","source":"Crossref","is-referenced-by-count":19,"title":["Molecular Imaging of the Noradrenergic System in Idiopathic Parkinson's Disease"],"prefix":"10.1016","author":[{"given":"Adjmal","family":"Nahimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin B.","family":"Kinnerup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Sommerauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Gjedde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Borghammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/bs.irn.2018.07.028_bb0010","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3233\/JPD-150604","article-title":"Neuropsychiatric symptoms in Parkinson's disease","volume":"5","author":"Aarsland","year":"2015","journal-title":"Journal of Parkinson's Disease"},{"issue":"10","key":"10.1016\/bs.irn.2018.07.028_bb0015","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/mds.20527","article-title":"A systematic review of prevalence studies of dementia in Parkinson's disease","volume":"20","author":"Aarsland","year":"2005","journal-title":"Movement Disorders"},{"issue":"6","key":"10.1016\/bs.irn.2018.07.028_bb0020","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.nucmedbio.2013.05.007","article-title":"Radiosynthesis and evaluation of new \u03b11-adrenoceptor antagonists as PET radioligands for brain imaging","volume":"40","author":"Airaksinen","year":"2013","journal-title":"Nuclear Medicine and Biology"},{"issue":"1","key":"10.1016\/bs.irn.2018.07.028_bb0025","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s12031-011-9539-x","article-title":"Changes in the mRNA levels of \u03b12A and \u03b12C adrenergic receptors in rat models of Parkinson's disease and l-DOPA-induced dyskinesia","volume":"46","author":"Alachkar","year":"2012","journal-title":"Journal of Molecular Neuroscience"},{"issue":"5","key":"10.1016\/bs.irn.2018.07.028_bb0030","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1001\/archpsyc.1996.01830050084013","article-title":"The contribution of alpha 2-noradrenergic mechanisms of prefrontal cortical cognitive function. Potential significance for attention-deficit hyperactivity disorder","volume":"53","author":"Arnsten","year":"1996","journal-title":"Archives of General Psychiatry"},{"issue":"1","key":"10.1016\/bs.irn.2018.07.028_bb0035","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/cne.20723","article-title":"Adaptive gain and the role of the locus coeruleus\u2013norepinephrine system in optimal performance","volume":"493","author":"Aston-Jones","year":"2005","journal-title":"Journal of Comparative Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2018.07.028_bb0040","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF00274983","article-title":"The human locus coeruleus complex: An immunohistochemical and three dimensional reconstruction study","volume":"77","author":"Baker","year":"1989","journal-title":"Experimental Brain Research"},{"issue":"3","key":"10.1016\/bs.irn.2018.07.028_bb0045","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.nucmedbio.2003.08.012","article-title":"New \u03b11-adrenoceptor antagonists derived from the antipsychotic sertindole\u2014Carbon-11 labelling and pet examination of brain uptake in the cynomolgus monkey","volume":"31","author":"Balle","year":"2004","journal-title":"Nuclear Medicine and Biology"},{"issue":"20","key":"10.1016\/bs.irn.2018.07.028_bb0050","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1212\/WNL.0b013e3181c2937c","article-title":"The locus ceruleus norepinephrine system: Functional organization and potential clinical significance","volume":"73","author":"Benarroch","year":"2009","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2018.07.028_bb0055","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0165-0173(03)00143-7","article-title":"The locus coeruleus\u2013noradrenergic system: Modulation of behavioral state and state-dependent cognitive processes","volume":"42","author":"Berridge","year":"2003","journal-title":"Brain Research. Brain Research Reviews"},{"issue":"5","key":"10.1016\/bs.irn.2018.07.028_bb0060","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S1474-4422(13)70054-1","article-title":"Idiopathic REM sleep behaviour disorder in the development of Parkinson's disease","volume":"12","author":"Boeve","year":"2013","journal-title":"The Lancet. Neurology"},{"issue":"4","key":"10.1016\/bs.irn.2018.07.028_bb0065","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/mds.1120","article-title":"Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy","volume":"16","author":"Boeve","year":"2001","journal-title":"Movement Disorders"},{"issue":"1","key":"10.1016\/bs.irn.2018.07.028_bb0070","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/cne.901970106","article-title":"A brainstem atlas of catecholaminergic neurons in man, using melanin as a natural marker","volume":"197","author":"Bogerts","year":"1981","journal-title":"The Journal of Comparative Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2018.07.028_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13670-018-0234-4","article-title":"Recent advances in cholinergic imaging and cognitive decline\u2014Revisiting the cholinergic hypothesis of dementia","volume":"7","author":"Bohnen","year":"2018","journal-title":"Current Geriatrics Reports"},{"issue":"1","key":"10.1016\/bs.irn.2018.07.028_bb0080","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/mds.27138","article-title":"How does Parkinson's disease begin? Perspectives on neuroanatomical pathways, prions, and histology","volume":"33","author":"Borghammer","year":"2018","journal-title":"Movement Disorders"},{"issue":"6","key":"10.1016\/bs.irn.2018.07.028_bb0085","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11910-016-0655-4","article-title":"Imaging dystemic dysfunction in Parkinson's disease","volume":"16","author":"Borghammer","year":"2016","journal-title":"Current Neurology and Neuroscience Reports"},{"issue":"2","key":"10.1016\/bs.irn.2018.07.028_bb0090","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiology of Aging"},{"issue":"1","key":"10.1016\/bs.irn.2018.07.028_bb0095","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1212\/WNL.37.1.42","article-title":"Parkinson's disease and dementia: Norepinephrine and dopamine in locus ceruleus","volume":"37","author":"Cash","year":"1987","journal-title":"Neurology"},{"key":"10.1016\/bs.irn.2018.07.028_bb0100","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0006-8993(84)90117-3","article-title":"Adrenergic receptors in Parkinson's disease","volume":"322","author":"Cash","year":"1984","journal-title":"Brain Research"},{"key":"10.1016\/bs.irn.2018.07.028_bb0105","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0079-6123(10)84017-8","article-title":"The challenge of non-motor symptoms in Parkinson's disease","volume":"184","author":"Chaudhuri","year":"2010","journal-title":"Progress in Brain Research"},{"issue":"4","key":"10.1016\/bs.irn.2018.07.028_bb0110","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1748-1716.1964.tb10446.x","article-title":"Ascending systems of catecholaminergic neurons from the lower brainstem","volume":"62","author":"Dahlstrom","year":"1964","journal-title":"Acta Physiologica Scandinavica"},{"issue":"11","key":"10.1016\/bs.irn.2018.07.028_bb0115","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/mds.23782","article-title":"Odor identification deficits identify Parkinson's disease patients with poor cognitive performance","volume":"26","author":"Damholdt","year":"2011","journal-title":"Movement Disorders"},{"issue":"1","key":"10.1016\/bs.irn.2018.07.028_bb0120","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1176\/appi.neuropsych.23.1.48","article-title":"The parkinsonian personality and concomitant depression","volume":"23","author":"Damholdt","year":"2011","journal-title":"The Journal of Neuropsychiatry and Clinical Neurosciences"},{"issue":"7","key":"10.1016\/bs.irn.2018.07.028_bb0125","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1136\/jnnp-2011-301817","article-title":"Dysfunction of the locus coeruleus-norepinephrine system and related circuitry in Parkinson's disease-related dementia","volume":"84","author":"Del Tredici","year":"2013","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1016\/bs.irn.2018.07.028_bb0130","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fnsys.2011.00031","article-title":"Noradrenaline and Parkinson's disease","volume":"5","author":"Delaville","year":"2011","journal-title":"Frontiers in Systems Neuroscience"},{"issue":"7","key":"10.1016\/bs.irn.2018.07.028_bb0135","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.nucmedbio.2005.04.017","article-title":"New-generation radiotracers for nAChR and NET","volume":"32","author":"Ding","year":"2005","journal-title":"Nuclear Medicine and Biology"},{"issue":"4","key":"10.1016\/bs.irn.2018.07.028_bb0140","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/syn.10281","article-title":"Evaluation of a new norepinephrine transporter PET ligand in baboons, both in brain and peripheral organs","volume":"50","author":"Ding","year":"2003","journal-title":"Synapse (New York, NY)"},{"issue":"2","key":"10.1016\/bs.irn.2018.07.028_bb0145","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1471-4159.2005.03202.x","volume":"94","author":"Ding","year":"2005","journal-title":"Journal of Neurochemistry"},{"issue":"3","key":"10.1016\/bs.irn.2018.07.028_bb0150","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0969-8051(00)00087-1","article-title":"Mutagenic activity of a fluorinated analog of the beta-adrenoceptor ligand carazolol in the Ames test","volume":"27","author":"Doze","year":"2000","journal-title":"Nuclear Medicine and Biology"},{"issue":"24","key":"10.1016\/bs.irn.2018.07.028_bb0155","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1007\/BF01485901","article-title":"Verteilung Von Noradrenalin Und Dopamin (3-Hydroxytyramin) Im Gehirn Des Menschen Und Ihr Verhalten Bei Erkrankungen Des Extrapyramidalen Systems","volume":"38","author":"Ehringer","year":"1960","journal-title":"Klinische Wochenschrift"},{"issue":"Pt 4","key":"10.1016\/bs.irn.2018.07.028_bb0160","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/brain\/aww006","article-title":"The coeruleus\/subcoeruleus complex in idiopathic rapid eye movement sleep behaviour disorder","volume":"139","author":"Ehrminger","year":"2016","journal-title":"Brain"},{"issue":"2","key":"10.1016\/bs.irn.2018.07.028_bb0165","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0361-9230(83)90045-X","article-title":"Monoamine distribution in primate brain V. Monoaminergic nuclei: Anatomy, pathways and local organization","volume":"10","author":"Felten","year":"1983","journal-title":"Brain Research Bulletin"},{"issue":"8","key":"10.1016\/bs.irn.2018.07.028_bb0170","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1001\/jamaneurol.2015.0703","article-title":"New clinical subtypes of Parkinson disease and their longitudinal progression: A prospective cohort comparison with other phenotypes","volume":"72","author":"Fereshtehnejad","year":"2015","journal-title":"JAMA Neurology"},{"issue":"4","key":"10.1016\/bs.irn.2018.07.028_bb0175","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/ana.410200403","article-title":"Locus ceruleus lesions and eosinophilic inclusions in MPTP-treated monkeys","volume":"20","author":"Forno","year":"1986","journal-title":"Annals of Neurology"},{"issue":"10","key":"10.1016\/bs.irn.2018.07.028_bb0180","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S1474-4422(08)70214-X","article-title":"Non-dopaminergic treatments in development for Parkinson's disease","volume":"7","author":"Fox","year":"2008","journal-title":"The Lancet. Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2018.07.028_bb0185","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.pneurobio.2009.10.012","article-title":"The discovery of central monoamine neurons gave volume transmission to the wired brain","volume":"90","author":"Fuxe","year":"2010","journal-title":"Progress in Neurobiology"},{"issue":"1","key":"10.1016\/bs.irn.2018.07.028_bb0190","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.neuroimage.2010.09.040","article-title":"Evaluation of [11C]MRB for assessment of occupancy of norepinephrine transporters: Studies with atomoxetine in non-human primates","volume":"56","author":"Gallezot","year":"2011","journal-title":"NeuroImage"},{"issue":"7","key":"10.1016\/bs.irn.2018.07.028_bb0195","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1093\/brain\/awt152","article-title":"The coeruleus\/subcoeruleus complex in rapid eye movement sleep behaviour disorders in Parkinson's disease","volume":"136","author":"Garcia-Lorenzo","year":"2013","journal-title":"Brain"},{"issue":"5","key":"10.1016\/bs.irn.2018.07.028_bb0200","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/ana.410320510","article-title":"Disease-specific patterns of locus coeruleus cell loss","volume":"32","author":"German","year":"1992","journal-title":"Annals of Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2018.07.028_bb0205","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/syn.20133","article-title":"Specific in vitro binding of (S,S)-[3H]MeNER to norepinephrine transporters","volume":"56","author":"Ghose","year":"2005","journal-title":"Synapse (New York, NY)"},{"issue":"Pt. 3","key":"10.1016\/bs.irn.2018.07.028_bb0210","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/brain\/awu369","article-title":"Imaging acetylcholinesterase density in peripheral organs in Parkinson's disease with 11C-donepezil PET","volume":"138","author":"Gjerl\u00f8ff","year":"2015","journal-title":"Brain"},{"issue":"11","key":"10.1016\/bs.irn.2018.07.028_bb0215","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S1474-4422(03)00555-6","article-title":"Dysautonomia in Parkinson's disease: Neurocardiological abnormalities","volume":"2","author":"Goldstein","year":"2003","journal-title":"The Lancet. Neurology"},{"issue":"1\u20132","key":"10.1016\/bs.irn.2018.07.028_bb0220","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jns.2011.04.011","article-title":"Autonomic dysfunction in PD: A window to early detection?","volume":"310","author":"Goldstein","year":"2011","journal-title":"Journal of the Neurological Sciences"},{"issue":"8","key":"10.1016\/bs.irn.2018.07.028_bb0225","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/0883-2897(89)90160-8","article-title":"Synthesis and regional mouse brain distribution of [11C]Nisoxetine, a norepinephrine uptake inhibitor","volume":"16","author":"Haka","year":"1989","journal-title":"International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology"},{"issue":"13","key":"10.1016\/bs.irn.2018.07.028_bb0230","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1002\/mds.25202","article-title":"An evidence base for noradrenergic deficits in Parkinson's disease","volume":"27","author":"Halliday","year":"2012","journal-title":"Movement Disorders"},{"issue":"9","key":"10.1016\/bs.irn.2018.07.028_bb0235","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.biopsych.2010.06.017","article-title":"Clinically relevant doses of methylphenidate significantly occupy norepinephrine transporters in humans in vivo","volume":"68","author":"Hannestad","year":"2010","journal-title":"Biological Psychiatry"},{"issue":"2","key":"10.1016\/bs.irn.2018.07.028_bb0240","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.parkreldis.2009.08.007","article-title":"A timeline for Parkinson's disease","volume":"16","author":"Hawkes","year":"2010","journal-title":"Parkinsonism & Related Disorders"},{"issue":"6","key":"10.1016\/bs.irn.2018.07.028_bb0245","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/mds.21956","article-title":"The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years","volume":"23","author":"Hely","year":"2008","journal-title":"Movement. Disorders"},{"issue":"5","key":"10.1016\/bs.irn.2018.07.028_bb0250","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1474-4422(13)70056-5","article-title":"Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: An observational cohort study","volume":"12","author":"Iranzo","year":"2013","journal-title":"The Lancet. Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2018.07.028_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2377-11-88","article-title":"Enhanced catecholamine transporter binding in the locus coeruleus of patients with early Parkinson disease","volume":"11","author":"Isaias","year":"2011","journal-title":"BMC Neurology"},{"key":"10.1016\/bs.irn.2018.07.028_bb0260","doi-asserted-by":"crossref","DOI":"10.3389\/fnhum.2011.00179","article-title":"A role for locus coeruleus in Parkinson tremor","volume":"5","author":"Isaias","year":"2012","journal-title":"Frontiers in Human Neuroscience"},{"issue":"1","key":"10.1016\/bs.irn.2018.07.028_bb0265","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0304-3940(83)90171-4","article-title":"Loss of pigmented dopamine-\u03b2-hydroxylase positive cells from locus coeruleus in senile dementia of alzheimer's type","volume":"39","author":"Iversen","year":"1983","journal-title":"Neuroscience Letters"},{"issue":"12","key":"10.1016\/bs.irn.2018.07.028_bb0270","first-page":"2008","article-title":"Detection of alpha2-adrenergic receptors in brain of living pig with 11C-yohimbine","volume":"47","author":"Jakobsen","year":"2006","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/bs.irn.2018.07.028_bb0275","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/bs.irn.2017.05.005","article-title":"Neuropathology of nonmotor symptoms of Parkinson's disease","volume":"133","author":"Jellinger","year":"2017","journal-title":"International Review of Neurobiology"},{"issue":"7","key":"10.1016\/bs.irn.2018.07.028_bb0280","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1523\/JNEUROSCI.09-07-02297.1989","article-title":"Regulation of subtypes of beta-adrenergic receptors in rat brain following treatment with 6-hydroxydopamine","volume":"9","author":"Johnson","year":"1989","journal-title":"The Journal of Neuroscience"},{"issue":"8","key":"10.1016\/bs.irn.2018.07.028_bb0285","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/sleep\/zsx101","article-title":"REM sleep behavior disorder and cognitive impairment in Parkinson's disease","volume":"40","author":"Jozwiak","year":"2017","journal-title":"Sleep"},{"issue":"4","key":"10.1016\/bs.irn.2018.07.028_bb0290","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.parkreldis.2009.12.010","article-title":"Cardiac 123I-MIBG uptake is reduced more markedly in patients with REM sleep behavior disorder than in those with early stage Parkinson's disease","volume":"16","author":"Kashihara","year":"2010","journal-title":"Parkinsonism & Related Disorders"},{"issue":"4","key":"10.1016\/bs.irn.2018.07.028_bb0295","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.neuroimage.2009.06.012","article-title":"In vivo mapping of the human locus coeruleus","volume":"47","author":"Keren","year":"2009","journal-title":"NeuroImage"},{"issue":"6","key":"10.1016\/bs.irn.2018.07.028_bb0300","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1001\/archneur.1984.04210080020007","article-title":"Cerebellar norepinephrine in patients with Parkinson's disease and control subjects","volume":"41","author":"Kish","year":"1984","journal-title":"Archives of Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2018.07.028_bb0305","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1212\/WNL.0b013e318224af8d","article-title":"Quantitative EEG as a predictive biomarker for Parkinson disease dementia","volume":"77","author":"Klassen","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/bs.irn.2018.07.028_bb0310","doi-asserted-by":"crossref","unstructured":"Knudsen K., Fedorova T. D., Hansen A. K., Sommerauer M., Otto M., Svendsen K. B., Nahimi A., Stokholm M. G., Pavese N., Beier C. P., Brooks D. J., and Borghammer P. In vivo staging of pathology in REM sleep behavior disorder\u2014A multi-modality imaging study. (In print in Lancet Neurology, May 2018) 17(7):618-628.","DOI":"10.1016\/S1474-4422(18)30162-5"},{"issue":"4","key":"10.1016\/bs.irn.2018.07.028_bb0315","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1016\/j.neuroimage.2009.11.035","article-title":"Elevated [(18)F]FDOPA utilization in the periaqueductal gray and medial nucleus accumbens of patients with early Parkinson's disease","volume":"49","author":"Kumakura","year":"2010","journal-title":"NeuroImage"},{"issue":"1","key":"10.1016\/bs.irn.2018.07.028_bb0320","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00213-011-2632-6","article-title":"Amphetamine challenge decreases yohimbine binding to \u03b12 adrenoceptors in landrace pig brain","volume":"222","author":"Landau","year":"2012","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/bs.irn.2018.07.028_bb0325","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s00259-014-2899-z","article-title":"Test-retest reliability of (11)C-ORM-13070 in PET imaging of \u03b12C-adrenoceptors in vivo in the human brain","volume":"42","author":"Lehto","year":"2015","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"issue":"10","key":"10.1016\/bs.irn.2018.07.028_bb0330","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1002\/mds.23823","article-title":"MDS task force on mild cognitive impairment in Parkinson's disease: Critical review of PD-MCI","volume":"26","author":"Litvan","year":"2011","journal-title":"Movement Disorders"},{"issue":"5","key":"10.1016\/bs.irn.2018.07.028_bb0335","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.nucmedbio.2005.04.005","article-title":"Modeling and analysis of PET studies with norepinephrine transporter ligands: The search for a reference region","volume":"32","author":"Logan","year":"2005","journal-title":"Nuclear Medicine and Biology"},{"issue":"6","key":"10.1016\/bs.irn.2018.07.028_bb0340","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.nucmedbio.2007.03.013","article-title":"Imaging the norepinephrine transporter in humans with (S,S)-[11C]O-methyl reboxetine and PET: Problems and progress","volume":"34","author":"Logan","year":"2007","journal-title":"Nuclear Medicine and Biology"},{"issue":"3","key":"10.1016\/bs.irn.2018.07.028_bb0345","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.tics.2016.01.001","article-title":"The locus coeruleus: Essential for maintaining cognitive function and the aging brain","volume":"20","author":"Mather","year":"2016","journal-title":"Trends in Cognitive Sciences"},{"issue":"7","key":"10.1016\/bs.irn.2018.07.028_bb0350","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/mds.26632","article-title":"Orthostatic hypotension and cognitive impairment in Parkinson's disease: Causation or association?","volume":"31","author":"McDonald","year":"2016","journal-title":"Movement Disorders"},{"issue":"3","key":"10.1016\/bs.irn.2018.07.028_bb0355","first-page":"235","article-title":"Potential antidepressant agents. \u03b1-Aryloxy-benzyl derivatives of ethanolamine and morpholine","volume":"19","author":"Melloni","year":"1984","journal-title":"European Journal of Medicinal Chemistry"},{"issue":"2","key":"10.1016\/bs.irn.2018.07.028_bb0360","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1177\/026988110001400202","article-title":"Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: Relevance to the actions of antidepressant agents","volume":"14","author":"Millan","year":"2000","journal-title":"Journal of Psychopharmacology (Oxford, England)"},{"issue":"6354","key":"10.1016\/bs.irn.2018.07.028_bb0365","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1126\/science.aaf3934","article-title":"\u03b22-Adrenoreceptor is a regulator of the \u03b1-synuclein gene driving risk of Parkinson's disease","volume":"357","author":"Mittal","year":"2017","journal-title":"Science (New York, NY)"},{"issue":"12","key":"10.1016\/bs.irn.2018.07.028_bb0370","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1212\/01.wnl.0000249313.25627.2e","article-title":"Reduced cardiac 123I-MIBG scintigraphy in idiopathic REM sleep behavior disorder","volume":"67","author":"Miyamoto","year":"2006","journal-title":"Neurology"},{"issue":"14","key":"10.1016\/bs.irn.2018.07.028_bb0375","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1212\/WNL.0b013e3182a6cbd5","article-title":"Nonmotor and diagnostic findings in subjects with de novo Parkinson disease of the DeNoPa cohort","volume":"81","author":"Mollenhauer","year":"2013","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/bs.irn.2018.07.028_bb0380","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.2967\/jnumed.116.178913","article-title":"PET quantification of the norepinephrine transporter in human brain with (S,S)-18F-FMeNER-D2","volume":"58","author":"Moriguchi","year":"2017","journal-title":"Journal of Nuclear Medicine"},{"issue":"5","key":"10.1016\/bs.irn.2018.07.028_bb0385","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/j.1471-4159.2011.07598.x","article-title":"Serotonergic modulation of receptor occupancy in rats treated with L-DOPA after unilateral 6-OHDA lesioning","volume":"120","author":"Nahimi","year":"2012","journal-title":"Journal of Neurochemistry"},{"issue":"3","key":"10.1016\/bs.irn.2018.07.028_bb0390","doi-asserted-by":"crossref","first-page":"392","DOI":"10.2967\/jnumed.114.145565","article-title":"Mapping \u03b12 adrenoceptors of the human brain with 11C-yohimbine","volume":"56","author":"Nahimi","year":"2015","journal-title":"Journal of Nuclear Medicine"},{"issue":"4","key":"10.1016\/bs.irn.2018.07.028_bb0395","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2967\/jnumed.117.190975","article-title":"Noradrenergic deficits in Parkinson's disease imaged with (11)C-MeNER","volume":"59","author":"Nahimi","year":"2018","journal-title":"Journal of Nuclear Medicine"},{"issue":"5","key":"10.1016\/bs.irn.2018.07.028_bb0400","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1523\/JNEUROSCI.17-05-01710.1997","article-title":"Pharmacology and distribution of norepinephrine transporters in the human locus coeruleus and raphe nuclei","volume":"17","author":"Ordway","year":"1997","journal-title":"The Journal of Neuroscience"},{"issue":"Pt 3","key":"10.1016\/bs.irn.2018.07.028_bb0405","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/brain\/awm302","article-title":"Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease","volume":"131","author":"Orimo","year":"2008","journal-title":"Brain"},{"key":"10.1016\/bs.irn.2018.07.028_bb0410","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.arr.2016.01.001","article-title":"(123)I-meta-iodobenzylguanidine (MIBG) cardiac scintigraphy in \u03b1-synucleinopathies","volume":"30","author":"Orimo","year":"2016","journal-title":"Ageing Research Reviews"},{"issue":"6316","key":"10.1016\/bs.irn.2018.07.028_bb0415","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/350350a0","article-title":"Expression cloning of a cocaine-and antidepressant-sensitive human noradrenaline transporter","volume":"350","author":"Pacholczyk","year":"1991","journal-title":"Nature"},{"issue":"2","key":"10.1016\/bs.irn.2018.07.028_bb0420","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/ana.24859","article-title":"Serotonin transporter in Parkinson's disease: A meta-analysis of PET studies","volume":"81","author":"Pagano","year":"2016","journal-title":"Annals of Neurology"},{"issue":"1\u20132","key":"10.1016\/bs.irn.2018.07.028_bb0425","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/0006-8993(92)91196-L","article-title":"Quantitative light microscopic autoradiographic localization of \u03b12-adrenoceptors in the human brain","volume":"585","author":"Pascual","year":"1992","journal-title":"Brain Research"},{"issue":"6","key":"10.1016\/bs.irn.2018.07.028_bb0430","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/00005072-199111000-00006","article-title":"The neuropathologic basis of different clinical subgroups of Parkinson's disease","volume":"50","author":"Paulus","year":"1991","journal-title":"Journal of Neuropathology & Experimental Neurology"},{"issue":"3","key":"10.1016\/bs.irn.2018.07.028_bb0435","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.neuroimage.2011.03.012","article-title":"Progression of monoaminergic dysfunction in Parkinson's disease: A longitudinal 18F-dopa PET study","volume":"56","author":"Pavese","year":"2011","journal-title":"NeuroImage"},{"issue":"1","key":"10.1016\/bs.irn.2018.07.028_bb0440","doi-asserted-by":"crossref","first-page":"15979","DOI":"10.1038\/s41598-017-16020-1","article-title":"Radioligand binding analysis of \u03b1 2 adrenoceptors with [11C]yohimbine in brain in vivo: Extended Inhibition Plot correction for plasma protein binding","volume":"7","author":"Phan","year":"2017","journal-title":"Scientific Reports"},{"issue":"3","key":"10.1016\/bs.irn.2018.07.028_bb0445","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/jcbfm.2014.225","article-title":"Quantification of [(11)C]yohimbine binding to \u03b12 adrenoceptors in rat brain in vivo","volume":"35","author":"Phan","year":"2015","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"issue":"13","key":"10.1016\/bs.irn.2018.07.028_bb0450","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1002\/mds.25109","article-title":"Thalamic noradrenaline in Parkinson's disease: Deficits suggest role in motor and non-motor symptoms","volume":"27","author":"Pifl","year":"2012","journal-title":"Movement Disorders"},{"issue":"12","key":"10.1016\/bs.irn.2018.07.028_bb0455","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/nrneurol.2014.205","article-title":"Neuroimaging in Parkinson disease: From research setting to clinical practice","volume":"10","author":"Politis","year":"2014","journal-title":"Nature Reviews. Neurology"},{"issue":"12","key":"10.1016\/bs.irn.2018.07.028_bb0460","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Movement Disorders"},{"issue":"11","key":"10.1016\/bs.irn.2018.07.028_bb0465","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1212\/WNL.0000000000001364","article-title":"Parkinson risk in idiopathic REM sleep behavior disorder: Preparing for neuroprotective trials","volume":"84","author":"Postuma","year":"2015","journal-title":"Neurology"},{"issue":"Suppl. 2","key":"10.1016\/bs.irn.2018.07.028_bb0470","doi-asserted-by":"crossref","first-page":"S732","DOI":"10.1002\/mds.22499","article-title":"123I-metaiodobenzylguanidine scintigraphy in Parkinson's disease and related disorders","volume":"24","author":"Rascol","year":"2009","journal-title":"Movement Disorders"},{"issue":"6","key":"10.1016\/bs.irn.2018.07.028_bb0475","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1093\/brain\/awh445","article-title":"Depression in Parkinson's disease: Loss of dopamine and noradrenaline innervation in the limbic system","volume":"128","author":"Remy","year":"2005","journal-title":"Brain"},{"issue":"1","key":"10.1016\/bs.irn.2018.07.028_bb0480","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.nucmedbio.2012.09.010","article-title":"Radiolabelling and PET brain imaging of the \u03b11-adrenoceptor antagonist Lu AE43936","volume":"40","author":"Risgaard","year":"2013","journal-title":"Nuclear Medicine and Biology"},{"issue":"5","key":"10.1016\/bs.irn.2018.07.028_bb0485","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1136\/jnnp-2013-306104","article-title":"REM sleep behaviour disorder is associated with worse quality of life and other non-motor features in early Parkinson's disease","volume":"85","author":"Rolinski","year":"2014","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"2","key":"10.1016\/bs.irn.2018.07.028_bb0490","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.bcp.2007.01.036","article-title":"Norepinephrine: The redheaded stepchild of Parkinson's disease","volume":"74","author":"Rommelfanger","year":"2007","journal-title":"Biochemical Pharmacology"},{"issue":"1","key":"10.1016\/bs.irn.2018.07.028_bb0495","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40035-017-0076-6","article-title":"Imaging biomarkers in Parkinson's disease and Parkinsonian syndromes: Current and emerging concepts","volume":"6","author":"Saeed","year":"2017","journal-title":"Translational Neurodegeneration"},{"issue":"10","key":"10.1016\/bs.irn.2018.07.028_bb0500","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.parkreldis.2015.08.024","article-title":"Mild cognitive impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study","volume":"21","author":"Santangelo","year":"2015","journal-title":"Parkinsonism & Related Disorders"},{"issue":"3","key":"10.1016\/bs.irn.2018.07.028_bb0505","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nrn2573","article-title":"The locus coeruleus and noradrenergic modulation of cognition","volume":"10","author":"Sara","year":"2009","journal-title":"Nature Reviews. Neuroscience"},{"key":"10.1016\/bs.irn.2018.07.028_bb0510","doi-asserted-by":"crossref","unstructured":"Sasaki, M., Shibata, E., Tohyama, K., Takahashi, J., Otsuka, K., Tsuchiya, K., et al. (2006). Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease. Neuroreport, 17(11), 1215\u20131218. https:\/\/doi.org\/10.1097\/01.wnr.0000227984.84927.a7.","DOI":"10.1097\/01.wnr.0000227984.84927.a7"},{"issue":"7","key":"10.1016\/bs.irn.2018.07.028_bb0515","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0969-8051(03)00079-9","article-title":"Specific in vivo binding to the norepinephrine transporter demonstrated with the PET radioligand, (S,S)-[11C]MeNER","volume":"30","author":"Schou","year":"2003","journal-title":"Nuclear Medicine and Biology"},{"key":"10.1016\/bs.irn.2018.07.028_bb0520","doi-asserted-by":"crossref","unstructured":"Schou, M., Zoghbi, S. S., Shetty, H. U., Shchukin, E., Liow, J.-S., Hong, J., et al. (2009). Investigation of the metabolites of (S,S)-[(11)C]MeNER in humans, monkeys and rats. Molecular Imaging and Biology, 11(1), 23\u201330. https:\/\/doi.org\/10.1007\/s11307-008-0175-y.","DOI":"10.1007\/s11307-008-0175-y"},{"issue":"1","key":"10.1016\/bs.irn.2018.07.028_bb0525","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0006-8993(94)91761-2","article-title":"Noradrenaline, dopamine and serotonin levels and metabolism in the human hypothalamus: Observations in Parkinson's disease and normal subjects","volume":"639","author":"Shannak","year":"1994","journal-title":"Brain Research"},{"issue":"2","key":"10.1016\/bs.irn.2018.07.028_bb0530","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.neuroscience.2005.11.033","article-title":"Distribution of norepinephrine transporters in the non-human primate brain","volume":"138","author":"Smith","year":"2006","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/bs.irn.2018.07.028_bb0535","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/brain\/awx348","article-title":"Evaluation of the noradrenergic system in Parkinson's disease: An 11C-MeNER PET and neuromelanin MRI study","volume":"141","author":"Sommerauer","year":"2018","journal-title":"Brain"},{"issue":"5","key":"10.1016\/bs.irn.2018.07.028_bb0540","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.neuint.2008.06.013","article-title":"Synthesis and preliminary evaluation of [(18)F]-fluoro-(2S)-exaprolol for imaging cerebral beta-adrenergic receptors with PET","volume":"53","author":"Stephenson","year":"2008","journal-title":"Neurochemistry International"},{"issue":"8","key":"10.1016\/bs.irn.2018.07.028_bb0545","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1177\/0269881113490326","article-title":"Functional neuroanatomy of the central noradrenergic system","volume":"27","author":"Szabadi","year":"2013","journal-title":"Journal of Psychopharmacology (Oxford, England)"},{"issue":"1","key":"10.1016\/bs.irn.2018.07.028_bb0550","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0022-3565(25)11249-4","article-title":"[3H]nisoxetine: A radioligand for quantitation of norepinephrine uptake sites by autoradiography or by homogenate binding","volume":"260","author":"Tejani-Butt","year":"1992","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"1\u20132","key":"10.1016\/bs.irn.2018.07.028_bb0555","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0006-8993(10)80041-1","article-title":"Effect of age on [3H]nisoxetine binding to uptake sites for norepinephrine in the locus coeruleus of humans","volume":"583","author":"Tejani-Butt","year":"1992","journal-title":"Brain Research"},{"issue":"1","key":"10.1016\/bs.irn.2018.07.028_bb0560","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0006-8993(93)91201-3","article-title":"Norepinephrine transporter sites are decreased in the locus coeruleus in Alzheimer's disease","volume":"631","author":"Tejani-Butt","year":"1993","journal-title":"Brain Research"},{"issue":"21\u221222","key":"10.1016\/bs.irn.2018.07.028_bb0565","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1007\/s00213-016-4416-5","article-title":"Neonatal domoic acid alters in vivo binding of [11C]yohimbine to \u03b12-adrenoceptors in adult rat brain","volume":"233","author":"Thomsen","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/bs.irn.2018.07.028_bb0570","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s00381-011-1424-y","article-title":"F\u00e9lix Vicq d'Azyr (1746\u20131794): Early founder of neuroanatomy and royal French physician","volume":"27","author":"Tubbs","year":"2011","journal-title":"Child's Nervous System: ChNS: Official Journal of the International Society for Pediatric Neurosurgery"},{"issue":"6","key":"10.1016\/bs.irn.2018.07.028_bb0575","first-page":"934","article-title":"Imaging beta-adrenoceptors in the human brain with (S)-1\u2032-[18F]fluorocarazolol","volume":"38","author":"van Waarde","year":"1997","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/bs.irn.2018.07.028_bb0580","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3389\/fnbeh.2012.00048","article-title":"The emerging role of norepinephrine in cognitive dysfunctions of Parkinson's disease","volume":"6","author":"Vazey","year":"2012","journal-title":"Frontiers in Behavioral Neuroscience"},{"issue":"2","key":"10.1016\/bs.irn.2018.07.028_bb0585","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0969-8051(02)00420-1","article-title":"Synthesis and in vivo evaluation of novel radiotracers for the in vivo imaging of the norepinephrine transporter","volume":"30","author":"Wilson","year":"2003","journal-title":"Nuclear Medicine and Biology"},{"issue":"3","key":"10.1016\/bs.irn.2018.07.028_bb0590","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/archneur.60.3.337","article-title":"Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases","volume":"60","author":"Zarow","year":"2003","journal-title":"Archives of Neurology"},{"key":"10.1016\/bs.irn.2018.07.028_bb0595","series-title":"l-DOPA action is associated with activation of \u03b12 adrenoceptors in Parkinson's disease","author":"Nahimi","year":"2017"}],"container-title":["International Review of Neurobiology","Imaging in Movement Disorders: Imaging Methodology and Applications in Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774218300576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774218300576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T15:03:22Z","timestamp":1751814202000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0074774218300576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9780128154182"],"references-count":118,"URL":"https:\/\/doi.org\/10.1016\/bs.irn.2018.07.028","relation":{},"ISSN":["0074-7742"],"issn-type":[{"value":"0074-7742","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}